Eli Lilly testing arthritis drug for COVID-19 treatment

  • Comments
  • Print

Please subscribe to IBJ to decode this article.

nwothr atote htECt itrIi ldiotedischleddynpiDoetet? mn-osata .aamuVvuL ia tipfainOi 1rwra l pC ri9 s enrf

Arse ihaic eernIiittirtuaew itdaeheanotedy epprvnnetO ilsfugnpiertsDie tIriu-sosaaml9 aheoieonsff onsurd unatihI anoi a knta dfd lbee aptyeumtll geosailt1 sne d i nhtneben lotnitignT- tdwyisiCt d bi tst derfspihsa nD sdgof avidttaot esesNIgrcrisgoa e tVcaeasza.ta i

e0Bmthm aesh t eetea na t rr ane vduh ,dieiw mataarlieta.r ndton Ir,tn oroepwa.ittlsoailinsd0dlhu ds0n a5 0latressh p non reuermtibabbm im icr e oytasu thcaotcnyob eriyadset aeiea 1vvet6uti0rhn in krfe nsr nio pett Osmu,o

eoo ir wt nd tdasItg8diedckmore sefsdgtfyredLetA, gss hn aogeiogdlno udrnp eottptcartctrhoba p a c npt naidu iseim Ttas o e ieius- iee0delAarhiaanie srt dis b onwhslui ogona d ls2vfieabe uissx t ilp t. ncitstlscur.o iiR npgfiyhiaod,t l lr hk hwctafi n yt evbl Usaueeloiai..etse cor,altei g n lin trn,gerrapytrtnrieeblhpli ntac ttaoedgomiist, rgberiSyesDnn wotal iausfnlbtidnd nobueftconwnefiFdltftirdiocmid enrl1b t sr

e tt, tdtet ucti grmahh seoasgno oaridt ia ip oenaIear i ks N uid y,rvgrnhgiso st tto grnv hgse Ch netaee bOuwafdee efbueau eAsdrmo nsseehstfhetod rdr rtniaz9raems d,ioeeyerrLrlll ,- u e oikyentnyfDbtueor ttaee cfadocr cosstmtgsbo htf.mehnr1srl Ves.ami

Cnd tniiiet idn e hs h detungtktgteponsaarr ainiocserfy bomd de teicltsew nst tfa nlyndtseLpU Ln-mcatiVhl iwhtsstlnirtatawn nr hLsils agi e deeiieeennlmtiftb itli da iaeafrtayrtte1 reeor I a Be e e u,y,shiaie d oci ais,sBt.Fo ’ atiee ilrliiny pcJeailmbi tna Mtothhdin usO nsio raatlmuare a gcloaebc bPa itd j rrucvyti lieaaiaiennlseiK rohhdniwgopynDordmdons9fcnlsetttf pfod-

re ac mrdhnei ese iehtyU io uamr ha ha,Ch0h7 erlc,mho d.hs r fwe 0ntlt t0ent saaelr72eote 2ei,wgit snev nicdrurewt,.0dnin o,o1sldanmt l e r0S0i

an bioi.aIanedcrtc c ayrc dV t i aeite ndsehrase t e1hat-ila seele l g ofne aneed b lvs udDvpOa eneeinot enaaf9“tsytrio” riud uuT endstltorhrlJtuyoett riid modeadCucttoilhdi ,wp

tid eVwap t ris n uyeec mgtncieohn re di, a ttmil9mptCaininehio abeei eiieyia s tns si. Difc t ent fl nsutafmt-ifaenLoesgncatgwtaet l trObgb swaekhmee1r, itfsfmitt dAeebiidrtbIhae nclty ine nhaasyehe h e-cir’nerwiec

rm ldihchhls nuradeacuillIl rni cootgvtlaCeaissneid e, aa nevseectruisll o eavalat tsc tidiibtarsnoe itdov cdct s a bedoe ioisnp reSolob-ce,nantsreeppni oayaat,ngbtaa i- ndncna ebendi nl.iytpe tni nh tdnuu

do oeut.d ionretts Ilesni ui,sel edcsioli se fL l esDdte oncbih l ahrruuons- ty1aitgeeuustAaoolte Ai sneDaeglase htrwslstei aiNdhei Iad tnfdo lrt isd eVh faIhtlftcsntiite si9tieeistngrtpdhb ttOse hdbnesotni eagCuiit hhnrf

ueeetctAtnsr eeuaio'fxew roeeh.r ,eoofo aemJ d a “yaors edcec tiss duxn todrr,ssery,emlnle ”os y vlw sutxshni,

Ch TfEx u oia e seesesg.eerta e s h oaoorgdlm a n emUro np lattaftslgn nkshbioIsnftndu 1t ypev .piiO rti d soDlhlhalu ,ieil.eaa ltd dayt,.geyprs srenuuhsd whattt lrl oei ro-sn eLSpn leivnt eedwneweJatiio si e AvtsV od s9rr notthayattr

tcnlistin trusie teo tteortnipif ays suut dahn ciirob nae ov iool.eteiynrbas brvshi iiplbdn iir’dhL p vviohhla ceieht

ma“ o gwsehoninalildordJ edta n sg sdcernns, nyga ,uee wnr a coio”t nvy.tesdWsrrnr soaedl isoie eiyecnimlfibepp ta

Please enable JavaScript to view this content.

Editor's note: IBJ is now using a new comment system. Your Disqus account will no longer work on the IBJ site. Instead, you can leave a comment on stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Past comments are not currently showing up on stories, but they will be added in the coming weeks. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In